Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients.
Barbe R, Belkouchi Y, Menu Y, Cohen R, David C, Kind M, Harguem S, Dawi L, Hadchiti J, Selhane F, Billet N, Ammari S, Bertin A, Lawrance L, Cervantes B, Hollebecque A, Balleyguier C, Cournede PH, Talbot H, Lassau N, Andre T.
Barbe R, et al. Among authors: ammari s.
Eur J Cancer. 2024 May;202:114020. doi: 10.1016/j.ejca.2024.114020. Epub 2024 Mar 16.
Eur J Cancer. 2024.
PMID: 38502988